Pharmaceutical market competition
2026 · 1st Quarter (Jan 1 - Mar 31)
NOVARTIS
Filed by CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Client
- NOVARTIS
- Filing UUID
- 12c6317f-0f5e-44f4-a324-52d33e3bf264
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Support for H.R. 1672 - Maintaining Investments in New Innovation Act (MINI Act)
Literal federal measure citations: H.R. 1672
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.